CureSearch Community Impact Award – Clinical Trials (CCIA-CT) is co-funded by Gateway for Cancer Research to award clinical trial researchers who are focusing on pilot or early phase (Phase Zero, I or II) clinical trial programs for pediatric cancers.
The thirteen CureSearch Community Impact Awards – Clinical Trials award recipients are:
A Phase II Study of Intraventricular Methotrexate
Variety Children's Hospital dba Miami Children's Hospital
Novel System for Solid Tumor Measurements in Pediatric Oncology Trials
The Children's Hospital Association
Cancer Germline Antigen (CGA) Vaccine for Relapsed Brain Tumors
University of Louisville Research Foundation, Inc.
A Early Phase Trial of Systemic Chemotherapy Penetration into DIPG Tumors
Regents of the University of Colorado, a body corporate, for and on behalf of the University of Colorado Denver
Early Phase Clinical Trial Expansion
Children's Hospital, Los Angeles
Los Angeles, CA
Infrastructure for Pediatric Clinical Cancer Trials at Children's Hospital
Children's Hospital of Pittsburgh of UPMC
Randomized Controlled Trial of Genistein in Pediatric Cancer
The Rector and Visitors of the University of Virginia
Peyton Manning Children's Hospital at St.Vincent Clinic Trials Application
St. Vincent Hospital and Health Care Center, Inc.
Lurie Children’s Clinical Trial Program
Ann & Robert H. Lurie Children's Hospital of Chicago
Support for CRAs who are involved in conducting clinical trials
Wayne State University
Supplemental Support for Uof MN Phase I/II Clinical Trial Program
Regents of the University of Minnesota - Twin Cities
Lead Coordinator for Optimizing the Developmental Therapeutics Program
Children's Healthcare of Atlanta, Inc.
Pilot Study of High Risk Neuroblastoma Induction Chemotherapy Without GCSF
Baylor College of Medicine
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial